Q3 2024 Earnings Call Transcript November 5, 2024 Masimo Corporation beats earnings expectations. Reported EPS is $0.98, expectations were $0.84. Operator: Ladies and gentlemen, good afternoon, and ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

In a report released today, Marie Thibault from BTIG maintained a Buy rating on Masimo (MASI – Research Report), with a price target of ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

Masimo has obtained an import ban for an Apple Watch feature in the USA. Apple sued back and won a Pyrrhic victory.

The intense legal feud between Apple and medical technology company Masimo has reached a pivotal moment with Apple winning a nominal victory in the latest round of court battles. A federal jury ...

Apple wins a symbolic $250 in damages as a federal jury finds that Masimo's smartwatch designs and charger infringe on Apple Watch patents. Despite the minimal monetary award, Apple claims the ...

Apple said in a statement that it was "glad the jury's decision today will protect the innovations we advance on behalf of our customers." ...

and the jury’s verdict is a victory for Masimo on that issue,” the medical device company said. The trial resulted from Apple’s countersuit in its ongoing legal battle with Masimo ...